The Hepatic Encephalopathy Treatment Market was valued at USD 1.69 Billion in 2025 and is projected to reach USD 2.94 Billion by 2035, expanding at a CAGR of 5.70% (2026–2035). Growth is primarily driven by rising global liver cirrhosis incidence, increasing alcohol-associated liver disease, hepatitis prevalence, aging populations, and improved diagnosis rates across the 7 major markets...